(Q37760524)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

review article

1 reference

title

Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Juan M Troyano-Luque

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

Gynecological Endocrinology

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

631-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20500106%20AND%20SRC:MED&resulttype=core&format=json

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Functional ovarian cysts in premenopausal and gynecologically healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Prevalence and histologic diagnosis of adnexal cysts in postmenopausal women: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The incidental postmenopausal adnexal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Clinical practice. Screening for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Familial ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The preclinical natural history of serous ovarian cancer: defining the target for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Precursor lesions of ovarian epithelial malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Endocrine signaling in ovarian surface epithelium and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Does smoking increase risk of ovarian cancer? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Risk factors for epithelial ovarian cancer by histologic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Recreational physical activity and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Serum 25-hydroxyvitamin D and the risk of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Role of endocrine and growth factors on the ovarian surface epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The importance of ERbeta signalling in the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ovarian cancer and hormone replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Hormone therapy and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ovarian carcinoma diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Symptoms associated with diagnosis of ovarian cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Simple Ovarian Cysts in Postmenopausal Patients with Breast Carcinoma Treated with Tamoxifen: Long-term Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Asymptomatic postmenopausal simple ovarian cyst

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Prevalence of simple adnexal cysts in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Paraovarian and paratubal cysts: preoperative diagnosis using transabdominal and transvaginal sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Brenner tumors of the ovary: sonographic and computed tomographic imaging features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Accuracy of ultrasonography with color Doppler in ovarian tumor: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Sonographic and clinical characteristics of struma ovarii

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Role of tumour markers in monitoring epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Screening for ovarian cancer in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Status of Tumor Markers in Ovarian Cancer Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Serum CA125 level before the development of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Recent advances in the pathology and classification of ovarian germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Novel alpha-fetoprotein-V messenger RNA isoforms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Inhibin as a diagnostic marker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Inhibin as a marker for granulosa-cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The role of inhibins B and antimüllerian hormone for diagnosis and follow-up of granulosa cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Potential markers that complement expression of CA125 in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The B7 family of immune-regulatory ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

B7-H4 overexpression in ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Validation of serum biomarkers for detection of early-stage ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Proteomic studies of early-stage and advanced ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Application of proteomics in ovarian cancer: which sample should be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Systematic evaluation of candidate blood markers for detecting ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Imaging of the ovary and adnexa: clinical issues and applications of MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Imaging evaluation of ovarian masses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Magnetic resonance evaluation of adnexal masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

CT and MRI findings of cystadenofibromas of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Patterns of misinterpretation of adnexal masses on CT and MR in an academic radiology department

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Histologic, surgical, and imaging correlations of adnexal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

The natural history of adnexal cysts incidentally detected at transvaginal ultrasound examination in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Breastfeeding and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

Paraovarian/paratubal cysts: comparison of transvaginal sonographic and pathological findings to establish diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.487611